跳至主要内容
临床试验/CTRI/2016/01/006495
CTRI/2016/01/006495进行中(未招募)不适用

Study of immunogenicity of Hepatitis B vaccine in Human Immunodeficiency Virus (HIV) infected children: a randomized controlled trial

Shahid Akhtar Siddiqui1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年1月8日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
60
试验地点
1
主要终点
To compare the efficacy of standard dose vs. double dose of Hepatitis B vaccination in HIV infected Children

研究概览

简要总结

This study is a randomized, single blind, parallel group, single centre trial comparing the efficacy and safety of standard dose vs. double dose of Hepatitis B vaccine given with a schedule of 0,1 and 6 months in 60 human immunodeficiency virus (HIV) infected children conducted at Antiretroviral Therapy (ART) centre and deptt of pediatrics at Moti Lal Nehru Medical College, Allahabad, Uttar Pradesh, India. The primary outcome measure is to compare the efficacy of standard dose vs. double dose of Hepatitis B vaccination in HIV infected children. The secondary outcome measures are to correlate seroprotection after Hepatitis B vaccination in HIV infected children with age, sex of patients, CD4 counts and HAART at vaccination.

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, fixed
盲法
Participant Blinded

入排标准

年龄范围
18.00 Month(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • HIV infected children (diagnosed as per NACO guidelines) HBsAg nonreactive.

排除标准

  • Received ≥1 dose of Hepatitis B vaccine in past Critically ill/moribund patients Consent not given.

结局指标

主要结局

To compare the efficacy of standard dose vs. double dose of Hepatitis B vaccination in HIV infected Children

时间窗: 12 weeks after complete vaccination

次要结局

  • To correlate seroprotection after Hepatitis B vaccination in HIV infected children with age, sex of patients, CD4 counts and HAART at vaccination(12 weeks after complete vaccination)

研究者

发起方
Shahid Akhtar Siddiqui
申办方类型
Other [Shahid Akhtar Siddiqui]

研究点 (1)

Loading locations...

相似试验